The Human Protein Atlas (https://www.proteinatlas.org) also revealed that patients with thyroid cancer who exhibited higher SRPX2 expression (n = 400) have shorter survival time than those with lower expression patients (n = 101) (Fig. 2E). The gene discussed is SRPX2; the disease is thyroid gland carcinoma.